Log in to save to my catalogue

Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report

Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764676

Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report

About this item

Full title

Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report

Publisher

Singapore: Springer Nature Singapore

Journal title

International cancer conference journal, 2024-01, Vol.13 (1), p.58-62

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

In recent years, immune checkpoint inhibitors have attracted attention in treatment for urothelial carcinoma. However, many clinical trials included only patients who had adequate renal function. The efficacy of immune checkpoint inhibitors for hemodialysis patients had not been well-documented. Herein, we report a case of a 73-years-old male with...

Alternative Titles

Full title

Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764676

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764676

Other Identifiers

ISSN

2192-3183

E-ISSN

2192-3183

DOI

10.1007/s13691-023-00636-4

How to access this item